BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu RC, She B, Gao WT, Ji YH, Xu DD, Wang QS, Wang SB. Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects. World J Gastroenterol 2019; 25(32): 4682-4695 [PMID: 31528094 DOI: 10.3748/wjg.v25.i32.4682]
URL: https://www.wjgnet.com/1007-9327/full/v25/i32/4682.htm
Number Citing Articles
1
Calvin Sidhu, Lokesh Yagnik. Recurrent hepatocellular carcinoma presenting as thoracic lymphadenopathyRespirology Case Reports 2021; 9(7) doi: 10.1002/rcr2.792
2
Benjamin Buchard, Camille Teilhet, Natali Abeywickrama Samarakoon, Sylvie Massoulier, Juliette Joubert-Zakeyh, Corinne Blouin, Christelle Reynes, Robert Sabatier, Anne-Sophie Biesse-Martin, Marie-Paule Vasson, Armando Abergel, Aicha Demidem. Two Metabolomics Phenotypes of Human Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease According to Fibrosis SeverityMetabolites 2021; 11(1): 54 doi: 10.3390/metabo11010054
3
Kanhaiyalal Agrawal, Sayak Choudhury, Arvind Suresh, Archi Agrawal, Gopinath Gnanasegaran. Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology2021; : 187 doi: 10.1007/978-3-030-68858-5_14
4
Dong Yi, Wang Wen-Ping, Won Jae Lee, Maria Franca Meloni, Dirk-Andre Clevert, Maria Cristina Chammas, Andrea Tannapfel, Antonella Forgione, Christoph Frank Dietrich. Hepatocellular carcinoma in the non-cirrhotic liverClinical Hemorheology and Microcirculation 2021; : 1 doi: 10.3233/CH-211309
5
Preethi Guniganti, Andrea S. Kierans. PET/MRI of the hepatobiliary system: Review of techniques and applicationsClinical Imaging 2021; 71: 160 doi: 10.1016/j.clinimag.2020.10.056
6
Kazuhiro Katayama. Treatment strategy for and malignant potential of hepatocellular carcinoma within the Milan criteriaKanzo 2021; 62(8): 439 doi: 10.2957/kanzo.62.439
7
Abu Bakar Hafeez Bhatti, Wajih Naqvi, Nusrat Yar Khan, Haseeb Haider Zia, Faisal Saud Dar, Zahid Amin Khan, Atif Rana. Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasionJournal of Cancer Research and Clinical Oncology 2021;  doi: 10.1007/s00432-021-03665-9
8
Sofi Dhanaraj, Tahir Shah, Joanne O'Rourke, Shishir Shetty. Hepatocellular carcinoma: update on treatment guidelinesGastrointestinal Nursing 2020; 18(Sup10): S18 doi: 10.12968/gasn.2020.18.Sup10.S18
9
Yi Luo, Lei Song, Xinyu Wang, Yujie Huang, Yongqiang Liu, Qi Wang, Ming Hong, Zhongyu Yuan. Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular CarcinomaFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01264
10
Shaobo Wang, Boqiao Li, Pengfei Li, Ran Xie, Quanshi Wang, Hong Shi, Jianfeng He. Feasibility of perfusion and early-uptake 18F-FDG PET/CT in primary hepatocellular carcinoma: a dual-input dual-compartment uptake modelJapanese Journal of Radiology 2021; 39(11): 1086 doi: 10.1007/s11604-021-01140-6
11
Shen-Yen Lin, Chien-Ming Chen, Bing-Shen Huang, Ying-Chieh Lai, Kuang-Tse Pan, Shi-Ming Lin, Sung-Yu Chu, Jeng-Hwei Tseng, Pierpaolo Alongi. A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectivenessPLOS ONE 2021; 16(3): e0249003 doi: 10.1371/journal.pone.0249003
12
Yushuang Qin, Siyuan Cheng, Yesen Li, Sijuan Zou, Minglong Chen, Dongling Zhu, Shi Gao, Hua Wu, Lei Zhu, Xiaohua Zhu. The development of a Glypican-3-specific binding peptide using in vivo and in vitro two-step phage display screening for the PET imaging of hepatocellular carcinomaBiomaterials Science 2020; 8(20): 5656 doi: 10.1039/D0BM00943A
13
David Brasse, Hélène Burckel, Patrice Marchand, Marc Rousseau, Ali Ouadi, Marie Vanstalle, Christian Finck, Patrice Laquerriere, Frédéric Boisson. Comparison of the [18F]-FDG and [18F]-FLT PET Tracers in the Evaluation of the Preclinical Proton Therapy Response in Hepatocellular CarcinomaMolecular Imaging and Biology 2021; 23(5): 724 doi: 10.1007/s11307-021-01602-3
14
Yunxi Liu, Yue Chen, Weidong Fei, Caihong Zheng, Yongquan Zheng, Miao Tang, Ying Qian, Xiao Zhang, Mengdan Zhao, Meng Zhang, Fengmei Wang. Silica-Based Nanoframeworks Involved Hepatocellular Carcinoma TheranosticFrontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.733792
15
Yaoru Huang, Po-Yung Chen, Tzu-Yen Cheng, Jeng-Fong Chiou. Hepatic Reirradiation for Patients with Recurrent Hepatocellular CarcinomaApplied Sciences 2021; 11(4): 1598 doi: 10.3390/app11041598
16
Jordan D. LeGout, Ryan E. Bailey, Candice W. Bolan, Andrew W. Bowman, Frank Chen, Joseph G. Cernigliaro, Lauren F. Alexander. Multimodality Imaging of Abdominopelvic Tumors with Venous InvasionRadioGraphics 2020; 40(7): 2098 doi: 10.1148/rg.2020200047
17
Anurima Patra, Hala Khasawneh, Garima Suman, Mark A. Nathan, Annie T. Packard, Geoffrey B. Johnson, Ajit H. Goenka. Atypical Metastases in the Abdomen and Pelvis From Biochemically Recurrent Prostate Cancer: 11C-Choline PET/CT With Multimodality CorrelationAmerican Journal of Roentgenology 2021; : 1 doi: 10.2214/AJR.21.26426
18
Brandon A. Howard, Terence Z. Wong. 18F-FDG-PET/CT Imaging for Gastrointestinal MalignanciesRadiologic Clinics of North America 2021; 59(5): 737 doi: 10.1016/j.rcl.2021.06.001
19
Angelo Castello, Egesta Lopci. Imaging HCC treated with radioembolization: review of the literature and clinical examples of choline PET utilityClinical and Translational Imaging 2020; 8(5): 377 doi: 10.1007/s40336-020-00384-y